论文部分内容阅读
目的:探讨根除幽门螺杆菌方案联合莫沙必利治疗功能性消化不良的临床疗效。方法:将60例确诊为功能性消化不良的患者随机分为治疗组、对照组各30例,治疗组予以根除HP方案联合莫沙必利治疗,对照组单独予以莫沙必利,按疗程治疗,统计治疗效果,进行对比。结果:治疗组有效率达86.67%,对照组有效率为73.33%,治疗组疗效优于对照组(P<0.05)。结论:根除幽门螺杆菌方案联合莫沙必利治疗功能性消化不良疗效优于单纯应用莫沙必利,值得临床推广。
Objective: To investigate the clinical efficacy of Helicobacter pylori eradication combined with mosapride in the treatment of functional dyspepsia. Methods: Sixty patients diagnosed as functional dyspepsia were randomly divided into treatment group and control group with 30 cases each. The treatment group was given HP combined with mosapride and the control group was given mosapride alone. , Statistical treatment, for comparison. Results: The effective rate was 86.67% in the treatment group and 73.33% in the control group. The curative effect in the treatment group was better than that in the control group (P <0.05). Conclusions: Efficacy of eradication of Helicobacter pylori combined with mosapride in the treatment of functional dyspepsia is superior to that of mosapride alone, which is worthy of clinical promotion.